• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Christina Herold, MD


  • Herold CI, Djulbegovic B, Hozo I, Lyman GH.Reliable data on 5- and 10-year survival provide accurate estimates of 15-year survival in estrogen receptor-positive early-stage breast cancer.Breast Cancer Res Treat. 2010 Jun;121(3):771-6.
  • Herold CI, Marcom PK.Primary systemic therapy in breast cancer: past lessons and new approaches.Cancer Invest. 2008 Dec;26(10):1052-9.
  • Herold CI, Blackwell KL.Aromatase inhibitors for breast cancer: proven efficacy across the spectrum of disease.Clin Breast Cancer. 2008 Feb;8(1):50-64. Review.
  • Herold CI, Blackwell KL.The impact of adjuvant endocrine therapy on reducing the risk of distant metastases in hormone-responsive breast cancer.Breast. 2008 Jan;17 Suppl 1:S15-24. Review.